Mallinckrodt settlement update
Mallinckrodt Pays $35 Million in Opioid Settlement
July 17, 2017
Pharmaceutical giant Mallinckrodt will pay a settlement of $35 million in a deal to make amends for its role in the opioid epidemic that has claimed the lives of some 30,000 Americans.
In settling for $35 million, Mallinckrodt will not formally admit any guilt in its role in the production and distribution of the prescription opioid painkiller oxycodone. Nevertheless, the company has been taken to task by the U.S. government for being too aggressive in its distribution of the potentially addictive medication, and for not taking sufficient steps to prevent the abuse of its pharmaceutical products.
Mallinckrodt had been under investigation by the U.S. Department of Justice for failing to detect and report “suspicious orders” of oxycodone. The company had, according to the government, distributed an “increasingly excessive quantity of oxycodone pulls without notifying DEA [the U.S. Drug Enforcement Administration].”
The settlement was reached in courts in New York and Michigan.
If your life, of those of your loved ones, has been jeopardized by opioid abuse, you may have a case. Contact TheLawFirm.com to learn how we can help you.
VA urged to address risks of opioids for veterans
More states added to lawsuit against opioid makers
Drugstores try to block cherokee opioid lawsuit
Insys settles Illinois opioid lawsuit
Insys Blue Cross and Blue Shield lawsuit
Fentanyl likely cause of boys death
FDA urged to block opioid suppliers
Opioid Atty Gen
FDA urged to remove opioids from market
FDA urges Opana to be pulled from the shelves
Oxycontin secret marketing
FDA approved drugs
FDA denies use of blue dye in opioids
FDA faults Canadian drugmaker for opioid abuse
Opioid lawsuit settlement
Opioids causing National epidemic
Opioid privileges revoked
TheLawFirm.com’s award winning lawyers have been featured in over 50 radio and television interviews including:
Real lawyers, real results!
no recovery, no fee!